Ramdan Hours:
Sun - Thu
9.30 AM - 2.30 PM
Iftar in --:--:--
🌙 Maghrib: --:--

Profiles of drug substances, excipients, and related methodology / (Record no. 10539)

MARC details
000 -LEADER
fixed length control field 05979cas a2200589 a 4500
001 - CONTROL NUMBER
control field 16993433
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20190509122247.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 040105c2014 ne ar 0 0eng c
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2004243091
015 ## - NATIONAL BIBLIOGRAPHY NUMBER
National bibliography number 025477390
Source dnb
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 101197857
Source DNLM
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 2131386-6
Source DE-600
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 007879119
Source Uk
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780128001738
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 18715125 (series)
022 0# - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1871-5125
ISSN-L 1871-5125
Incorrect ISSN 0099-5428
Source j
030 ## - CODEN DESIGNATION
CODEN PDSEBJ
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)ocm53979632
040 ## - CATALOGING SOURCE
Original cataloging agency NjPERS
Language of cataloging eng
Transcribing agency NjPERS
Modifying agency DNLM
-- OUCA
-- OCoLC
-- HEBIS
-- GBVCP
-- DEBBG
-- UKMGB
-- GU
-- WaSeSS
-- DLC
Description conventions rda
042 ## - AUTHENTICATION CODE
Authentication code pcc
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RS189
Item number .A582
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 740 AA1
Item number A55
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1
Edition number 23
Item number P
245 00 - TITLE STATEMENT
Title Profiles of drug substances, excipients, and related methodology /
Statement of responsibility, etc Harry G. Brittain.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Amsterdam ;
Name of publisher, distributor, etc Elsevier Academic Press,
Date of publication, distribution, etc c2014.
300 ## - PHYSICAL DESCRIPTION
Extent v. :
Other physical details ill. ;
Dimensions 24 cm.
310 ## - CURRENT PUBLICATION FREQUENCY
Current publication frequency Annual
336 ## - CONTENT TYPE
Source rdacontent
Content type term text
337 ## - MEDIA TYPE
Source rdamedia
Media type term unmediated
338 ## - CARRIER TYPE
Source rdacarrier
Carrier type term volume
500 ## - GENERAL NOTE
General note Includes index.
500 ## - GENERAL NOTE
General note pharmacy bookfair2016
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Front Cover; Profiles of Drug Substances, Excipients, and Related Methodology; Copyright; Contents; Preface to Volume 39; Chapter One: Azithromycin; Background; 1. Description; 1.1. Nomenclature; 1.1.1. Systematic chemical names [2-5]; 1.1.2. Nonproprietary names; 1.1.3. Proprietary names [3,7,8]; 1.2. Formulae[2,3]; 1.2.1. Empirical formula, molecular weight, CAS number; 1.2.2. Structural formula; 1.3. Elemental analysis; 1.4. Appearance [2]; 2. Methods of Preparation of Azithromycin; 3. Physical Characteristics; 3.1. Specific optical rotation [5,21]; 3.2. Ionization constant [22]. 3.3. Solubility characteristics [21]3.4. Partition coefficient; 3.5. Particle morphology; 3.6. Crystallographic properties; 3.6.1. Single crystal structure; 3.6.2. X-ray powder diffraction pattern [28]; 3.7. Hygroscopicity; 3.8. Thermal methods of analysis; 3.8.1. Melting behavior; 3.8.2. Differential scanning calorimetry [25]; 3.8.3. Thermogravimetric analysis; 3.8.4. Karl Fischer titration (KFT) [25]; 3.8.5. Boiling point, enthalpy of vapor, flash point, and vapor pressure; 3.9. Spectroscopy; 3.9.1. UV/Vis spectroscopy; 3.9.2. Vibrational spectroscopy [32]. 3.9.3. Nuclear magnetic resonance spectrometry [33]3.9.3.1. 1H NMR spectrum [33]; 3.9.3.2. 13C NMR spectrum [33]; 3.10. Mass spectrometry [34]; 4. Methods of Analysis; 4.1. Compendial methods of analysis; 4.1.1. Identification; 4.1.1.1. IR spectrum of Azithromycin; 4.1.1.2. HPLC drug chromatogram; 4.1.2. Impurity Analysis [47]; 4.1.3. Other tests; 4.1.3.1. Water [47]; 4.1.3.2. Sulphated ash [47]; 4.1.4. Assay method [47]; 4.1.4.1. Liquid chromatography; 4.2. Electrochemical methods of analysis; 4.2.1. Voltammetry; 4.2.2. Coulometry; 4.3. Spectroscopic methods of analysis. 4.3.1. Spectrophotometry4.3.2. Spectrofluorimetry; 4.3.3. Colorimetry; 4.4. Chromatographic methods of analysis; 4.4.1. Electrophoresis; 4.4.2. Thin-layer chromatography; 4.4.3. High-performance liquid chromatography; 4.5. Determination in body fluids and tissues; 5. Stability; 6. Clinical Applications; 6.1. An overview; 6.2. Antimicrobial spectrum susceptibility; 6.3. Mechanism of action; 6.4. Resistance to macrolides; 6.5. Actions other than antimicrobial effects; 6.6. Clinical uses and dosing; 6.7. ADME profile; 6.8. Side effects; 6.9. Drug interactions; References; Chapter Two: Cefdinir. 1. Description1.1. Nomenclature; 1.1.1. Systematic chemical names; 1.1.2. Non-proprietary names; 1.1.3. Proprietary names; 1.2. Formulae; 1.2.1. Empirical formula, molecular weight, and CAS number; 1.2.2. Structural formula; 1.3. Elemental analysis; 1.4. Appearance; 2. Uses and Applications; 3. Methods of Preparation; 4. Physical Characteristics; 4.1. Ionization constant; 4.2. Solubility; 4.3. X-ray powder diffraction; 4.4. Thermal methods of analysis; 4.4.1. Melting point; 4.4.2. Differential scanning calorimetry; 5. Spectral Properties; 5.1. Ultraviolet spectroscopy.
520 ## - SUMMARY, ETC.
Summary, etc Volumes in this widely revered series present comprehensive reviews of drug substances and additional materials, with critical review chapters that summarize information related to the characterization of drug substances and excipients. This organizational structure meets the needs of the pharmaceutical community and allows for the development of a timely vehicle for publishing review materials on this topic. The scope of the Profiles series encompasses review articles and database compilations that fall within one of the following six broad categories: Physical profiles of drug substances and excipients; Analytical profiles of drug substances and excipients; Drug metabolism and pharmacokinetic profiles of drug substances and excipients; Methodology related to the characterization of drug substances and excipients; Methods of chemical synthesis; and Reviews of the uses and applications for individual drug substances, classes of drug substances, or excipients.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Analysis
Form subdivision Periodicals.
9 (RLIN) 8548
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Excipients
General subdivision Analysis
Form subdivision Periodicals.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Excipients
General subdivision analysis
Form subdivision Periodicals.
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Excipients
General subdivision chemistry
Form subdivision Periodicals.
9 (RLIN) 8552
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Excipients
General subdivision pharmacokinetics
Form subdivision Periodicals.
9 (RLIN) 8553
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical Preparations
Form subdivision Periodicals.
9 (RLIN) 8554
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical Preparations
General subdivision analysis
Form subdivision Periodicals.
9 (RLIN) 8555
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical Preparations
General subdivision chemistry
Form subdivision Periodicals.
9 (RLIN) 8556
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacokinetics
Form subdivision Periodicals.
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Médicaments
General subdivision Analyse
Form subdivision Périodiques.
9 (RLIN) 8558
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Excipients
General subdivision Analyse
Form subdivision Périodiques.
9 (RLIN) 8559
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Excipients.
Source of heading or term fmesh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Préparations pharmaceutiques
General subdivision analyse.
Source of heading or term fmesh
9 (RLIN) 8561
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacocinétique.
Source of heading or term fmesh
9 (RLIN) 8562
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brittain, Harry G.
Relator term editor
856 ## - ELECTRONIC LOCATION AND ACCESS
Materials specified Abstract
Uniform Resource Identifier <a href="http://repository.fue.edu.eg/xmlui/handle/123456789/1840">http://repository.fue.edu.eg/xmlui/handle/123456789/1840</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Books
Holdings
Lost status Source of classification or shelving scheme Damaged status Not for loan Collection code Home library Current library Shelving location Date acquired Source of acquisition Cost, normal purchase price Acquisition method Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
  Dewey Decimal Classification     Pharmacy ( Pharmaceutical Technology ) Main library Main library A10 14/02/2016 Osiris Bookshop 2205.00 Purchase   615.1 P v.39 00012561 19/02/2025 14/02/2016 Books